HYPERSTEALTH Trademark

Trademark Overview


On Friday, May 7, 2021, a trademark application was filed for HYPERSTEALTH with the United States Patent and Trademark Office. The USPTO has given the HYPERSTEALTH trademark a serial number of 90696222. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, September 13, 2024. This trademark is owned by Generate Biomedicines, Inc.. The HYPERSTEALTH trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development

Pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic pharmaceuticals for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psy...

Biological and chemical agents for scientific and research use

Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products
hyperstealth

General Information


Serial Number90696222
Word MarkHYPERSTEALTH
Filing DateFriday, May 7, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, September 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements


Goods and ServicesDownloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development
Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic pharmaceuticals for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy
Pseudo MarkHYPER STEALTH
Goods and ServicesBiological and chemical agents for scientific and research use
Goods and ServicesProviding temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, August 9, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, July 1, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenerate Biomedicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameGenerate Biomedicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Wednesday, January 12, 2022ASSIGNED TO EXAMINER
Monday, August 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 12, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 5, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, July 5, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 5, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, July 5, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 30, 2023SOU EXTENSION 1 GRANTED
Thursday, March 30, 2023SOU EXTENSION 1 FILED
Wednesday, March 13, 2024SOU EXTENSION 3 FILED
Saturday, April 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 15, 2023SOU EXTENSION 2 FILED
Friday, September 15, 2023SOU EXTENSION 2 GRANTED
Tuesday, September 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024SOU EXTENSION 4 GRANTED
Friday, September 13, 2024SOU EXTENSION 4 FILED